Retour sur lavenir.net
   KBC 114.850 € (+2,00 %)     COFINIMMO 84.500 € (+0,54 %)     D'IETEREN GROUP 172.000 € (+2,69 %)     AB INBEV 71.860 € (-0,06 %)     ARGENX SE 699.200 € (-0,26 %)     UMICORE 26.080 € (-0,38 %)     KINEPOLIS GROUP 29.650 € (+1,19 %)     VIOHALCO 19.700 € (+3,36 %)     AZELIS GROUP 10.240 € (-0,68 %)     COLRUYT 33.120 € (-1,02 %)     UCB 243.900 € (+0,79 %)     GBL 82.150 € (+1,42 %)     VAN DE VELDE 30.500 € (-0,65 %)     TITAN S.A. 48.140 € (+0,59 %)     ACKERMANS V.HAAREN 280.100 € (+2,23 %)     ONWARD MEDICAL 2.875 € (+1,59 %)     TEXAF 44.000 € (+0,92 %)     WDP 22.260 € (+1,09 %)     CAMPINE 236.000 € (+2,16 %)     DEME GROUP 189.000 € (+1,07 %)     SYENSQO 67.200 € (+1,05 %)     PROXIMUS 6.850 € (-0,72 %)     MELEXIS 82.150 € (+0,86 %)     SOLVAY 26.200 € (+0,77 %)     SOFINA 228.400 € (+2,06 %)     BEKAERT 41.650 € (+0,48 %)     LOTUS BAKERIES 10 940.000 € (+0,92 %)     MONTEA 68.300 € (+1,94 %)     AGEAS 68.450 € (+0,51 %)     ONTEX GROUP 2.680 € (+0,75 %)     BANQUP GROUP 2.240 € (-8,57 %)     IBA 15.600 € (+1,43 %)     SIPEF 95.300 € (+0,11 %)     CIE BOIS SAUVAGE 316.000 € (+0,96 %)     VASTNED 29.550 € (+0,17 %)     TUBIZE-FIN 211.600 € (+1,83 %)     INCLUSIO SA/NV 17.250 € (+5,18 %)     CARE PROPERTY INV. 13.200 € (+0,15 %)     DECEUNINCK 2.080 € (+0,97 %)     ELIA GROUP 139.300 € (+1,24 %)     BPOST 1.802 € (+1,92 %)     SHURGARD 23.850 € (-0,21 %)     RETAIL ESTATES 70.600 € (+0,86 %)     CMB.TECH 14.560 € (-0,14 %)     FAGRON 25.200 € (+0,80 %)     AEDIFICA 71.800 € (+0,35 %)     GIMV 49.850 € (+0,71 %)     BARCO 9.190 € (+0,49 %)     CENERGY 25.320 € (+5,41 %)     TESSENDERLO 21.350 € (-0,23 %)     WERELDHAVE BELGIUM 53.000 € (+1,53 %)     ASCENCIO 50.300 € (+0,70 %)     EVS BROADC.EQUIPM. 31.850 € (+2,25 %)     KBC ANCORA 81.300 € (+2,65 %)     QUESTFOR GR-PRICAF 3.036 € (+1,18 %)     XIOR 27.500 € (+0,73 %)     ATENOR 1.800 € (+0,28 %)     AGFA-GEVAERT 0.466 € (+1,20 %)     BREDERODE 102.200 € (+0,39 %)     FLUXYS BELGIUM D 19.900 € (+0,25 %)  
   FDJ UNITED 23.130 € (+0,39 %)     VIRIDIEN 114.300 € (-0,78 %)     74SOFTWARE 39.000 € (+1,56 %)     PLUXEE 11.900 € (+0,93 %)     WENDEL 90.350 € (+1,63 %)     SCOR SE 32.240 € (+1,07 %)     TOTALENERGIES 77.620 € (-1,31 %)     OVH 11.660 € (-0,68 %)     PHARMING GROUP 1.194 € (+6,75 %)     EUTELSAT COMMUNIC. 3.978 € (+4,79 %)     NEXITY 8.375 € (+2,95 %)     SANOFI 77.200 € (+0,42 %)     EURAZEO 46.780 € (+2,01 %)     METROPOLE TV 11.500 € (0,00 %)     DANONE 61.720 € (-0,23 %)     BUREAU VERITAS 27.110 € (+0,78 %)     THALES 231.800 € (+0,91 %)     LAGARDERE SA 17.800 € (+1,02 %)     SOCIETE GENERALE 71.670 € (+4,17 %)     MEDIANTECHNOLOGIES 5.630 € (+4,45 %)     CAPGEMINI 104.900 € (+1,75 %)     LECTRA 16.760 € (0,00 %)     EMEIS 15.100 € (+2,72 %)     CROSSJECT 2.335 € (+3,78 %)     PROSUS 40.780 € (+4,40 %)     ALTRI SGPS 5.280 € (+0,76 %)     LVMH 479.300 € (+1,42 %)     AEGON 7.582 € (+1,47 %)     BOLLORE 5.470 € (+1,77 %)     AXA 40.430 € (+0,77 %)     VIVENDI SE 2.362 € (+0,68 %)     TECHNIP ENERGIES 37.240 € (+1,64 %)     BNP PARIBAS ACT.A 92.530 € (+2,89 %)     MAGNUM 13.844 € (-0,33 %)     VALBIOTIS 1.090 € (+4,21 %)     TEIXEIRA DUARTE 0.443 € (+4,73 %)     NANOBIOTIX 36.340 € (-0,33 %)     BIO-UV GROUP 1.395 € (0,00 %)     BAM GROEP KON 9.735 € (+6,39 %)     ASML HOLDING 1 425.200 € (+1,15 %)     KERING 247.800 € (+2,40 %)     L'OREAL 369.150 € (+2,07 %)     KALRAY 12.620 € (+14,10 %)     ABL Diagnostics 3.400 € (-2,86 %)     BE SEMICONDUCTOR 279.800 € (+2,27 %)     SCHNEIDER ELECTRIC 276.200 € (+2,66 %)     TRIGANO 157.900 € (+2,80 %)     AYVENS 11.300 € (+2,17 %)     ORANGE 18.155 € (-0,27 %)     AIR FRANCE -KLM 11.005 € (+7,31 %)     SAINT GOBAIN 77.820 € (+3,37 %)     ESSILORLUXOTTICA 176.000 € (+1,59 %)     GALP ENERGIA-NOM 18.835 € (-1,36 %)     PERNOD RICARD 65.300 € (+0,83 %)     CSG 18.814 € (+0,13 %)     STMICROELECTRONICS 57.730 € (-0,35 %)     HERMES INTL 1 651.000 € (+2,87 %)     VALEO 13.210 € (+4,51 %)     CREDIT AGRICOLE 17.580 € (+1,85 %)     ASM INTERNATIONAL 908.600 € (+0,87 %)  
News Réglementées
11/05/2026 07:36

LR Health & Beauty SE publishes results for first quarter of 2026

EQS-News: LR Health & Beauty SE / Key word(s): Quarter Results
LR Health & Beauty SE publishes results for first quarter of 2026

11.05.2026 / 07:36 CET/CEST
The issuer is solely responsible for the content of this announcement.


LR Health & Beauty SE publishes results for first quarter of 2026

  • Q1 2026 sales reached EUR 60.8 million, with normalized EBITDA of EUR 5.2 million
  • Focus in FY 2026 on consistent continuation of strategic initiatives aimed at achieving sustainably positive business development
  • Successful LR Business Days in April, featuring an innovative product launch, deliver additional momentum

Ahlen, 11 May 2026 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today publishes its preliminary figures for the first quarter of 2026.

Given generally subdued consumer sentiment in many European markets, the LR Group generated sales (revenue from goods sold) of EUR 60.8 million in the first three months of the 2026 financial year (Q1 2025: EUR 74.0 million), representing a 17.8% decrease compared with the same period last year. Normalized EBITDA reached EUR 5.2 million in the first quarter of 2026 (Q1 2025: EUR 8.2 million), whilst reported EBITDA stood at EUR 3.3 million (Q1 2025: EUR 7.4 million). The decrease in EBITDA is primarily attributable to the lower sales level as well as one-off effects relating to the ongoing financial restructuring.

Jörg Körfer, CEO of LR Health & Beauty SE, comments: “During the first quarter of 2026, we reached important milestones in the realignment of our financing structure. Accordingly, throughout the current year we will continue to focus on advancing our strategic initiatives in order to create the conditions for sustainably positive business development and growth. The successful outcome of our Business Days in April, attended by thousands of our distributors and featuring a promising product launch, clearly demonstrated that we can look to the future with confidence and achieve great success together with a strong partner community.”

LR continues to focus on the consistent expansion of its product portfolio with in-house production of selected top-selling health and beauty products. As part of the LR Business Days in April 2026, the relaunch of the 5in1 Beauty Elixir and the 5in1 Men’s Shot was presented, both of which are also to be manufactured in-house in future. The new products have already been received very positively by distributors, as reflected in the successful product launch. At the same time, in order to strengthen the partner community, the LR Group has introduced targeted adjustments to its career plan to support the successful career development of its distributors. 

2025 Sustainability Report

In addition, LR has published its 2025 Sustainability Report. The report documents the company’s progress in the area of sustainability and underscores the LR Group’s commitment to combining economic success with environmental responsibility and social engagement. The Sustainability Report 2025 is available on the company’s website at https://ir.lrworld.com.

Annual Report 2025

LR will publish the audited annual and consolidated financial statements for the 2025 financial year following the completion of the financial restructuring process. As part of this, guidance for the current 2026 financial year will also be announced, as usual.

The preliminary report for the first quarter of 2026 is available online from today on the company’s website at https://ir.lrworld.com/.


LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.


Contact:

PR Contact:

LR Health & Beauty SE 
Almut Kellermeyer  
Head of Corporate Communication  
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/


IR Contact:

cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de



11.05.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:LR Health & Beauty SE
Kruppstr. 55
59227 Ahlen
Germany
Phone:+49 238270600
E-mail:info@lrworld.com
Internet:www.lrworld.com
ISIN:NO0013149658
WKN:A3H3FM
Listed:Regulated Unofficial Market in Frankfurt; Stockholm
EQS News ID:2324326

 
End of NewsEQS News Service

2324326  11.05.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière